1. Home
  2. GSUN vs ENLV Comparison

GSUN vs ENLV Comparison

Compare GSUN & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$1.56

Market Cap

24.0M

Sector

Real Estate

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.24

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSUN
ENLV
Founded
1997
2005
Country
China
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
26.6M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
GSUN
ENLV
Price
$1.56
$1.24
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
212.4K
11.3M
Earning Date
02-12-2026
11-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,314,724.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
526.22
N/A
52 Week Low
$1.25
$0.83
52 Week High
$5.25
$2.10

Technical Indicators

Market Signals
Indicator
GSUN
ENLV
Relative Strength Index (RSI) 43.65 66.31
Support Level $1.29 $0.89
Resistance Level $1.58 $1.06
Average True Range (ATR) 0.17 0.15
MACD 0.03 0.03
Stochastic Oscillator 72.09 38.69

Price Performance

Historical Comparison
GSUN
ENLV

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: